NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Overview of attention for article published in Breast Cancer Research, December 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,715 followers.

RT @jamecancerdoc: @NSABPFoundation @NRGonc FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib fo…

09 Dec 2019

Reply Repost Favourite

@NSABPFoundation @NRGonc FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ #breastcancer Increased pCR with Neratinib + trastuzumab+ Chemo https://t

09 Dec 2019

Reply Repost Favourite